Mirae Asset Global Investments’s ProQR Therapeutics PRQR Stock Holding History

Mirae Asset Global Investments’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-157,540	Closed	-$143K	–	2435
2022 Q1	$143K	Sell	157,540 -29,123	-16%	-$97.6K	﹤0.01%	1552
2021 Q4	$1.5M	Buy	186,663 +35,261	+23%	+$269K	﹤0.01%	1185
2021 Q3	$1.27M	Buy	151,402 +28,319	+23%	+$185K	﹤0.01%	1230
2021 Q2	$830K	Buy	+123,083	New	+$794K	﹤0.01%	1319
2020 Q4	–	Sell	-40,342	Closed	-$193K	–	1577
2020 Q3	$193K	Buy	40,342 +12,730	+46%	+$66.6K	﹤0.01%	1432
2020 Q2	$168K	Buy	27,612 +11,814	+75%	+$63.8K	﹤0.01%	1413
2020 Q1	$87K	Buy	15,798 +1,711	+12%	+$13.1K	﹤0.01%	1386
2019 Q4	$140K	Buy	+14,087	New	+$110K	﹤0.01%	1453

Other funds holding PRQR

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mirae Asset Global Investments's PRQR Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 157,540 shares — an estimated $143K sold.

Mirae Asset Global Investments first reported a position in PRQR in Q4 2019 and held it in 8 quarters. The position peaked at $1.5M in Q4 2021. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.

Mirae Asset Global Investments reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
Mirae Asset Global Investments sold 157,540 ProQR Therapeutics shares in Q2 2022, an estimated $143K.
Mirae Asset Global Investments first reported a position in ProQR Therapeutics in Q4 2019 and held it in 8 quarters.
Mirae Asset Global Investments's ProQR Therapeutics position peaked at $1.5M in Q4 2021.
51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.